Home › Funds › Renaissance Technologies › BCLI
Renaissance Technologies position in BCLI
BRAINSTORM CELL THERAPEUTICS
Latest position (Q3 2023)203.60K sh
Reported value held$41
Portfolio Weight0.00%
First reportedQ2 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 17.10K | $47.00K | New |
| Q3 2022 | 55.70K | $246.00K | Add |
| Q4 2022 | 11.80K | $19 | Reduce |
| Q2 2023 | 206.80K | $426 | New |
| Q3 2023 | 203.60K | $41 | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.